COVID-19. COVID-19, virus identified
Conditions
Interventions
Intervention 1: First intervention group: Laris-Tokrium polium compound herbal medicine. This compound will be prepared as a herbal distillate in 500 cc bottles by Sarab Production and Service Company
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
7 Years to No maximum
Inclusion criteria
Inclusion criteria: High-risk people exposed to the corona virus Older than 7 years Having an informed consent form to participate in the study Not participation in another simultaneous clinical trial
Exclusion criteria
Exclusion criteria: Pregnant women Breastfeeding women Having liver or renal failure, according to the individual or family declaration
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptoms of corona-virus. Timepoint: Day 5, 10, 15 and 20 of the taking combined herbal medicine. Method of measurement: Corona-virus Symptoms Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: During and at the end of intervention. Method of measurement: Side effects questionnaire.;Satisfaction with drug use. Timepoint: At the end of intervention. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyyed mohammad bagher fazljou
Tabriz University of Medical Sciences
Outcome results
None listed